Cupid shares climbed significantly after a positive business update for the April-June quarter. The company raised its FY27 revenue guidance to over Rs 660 crore. This upward revision reflects strong performance and expanding global opportunities. Cupid’s management highlighted diversification and growth across multiple business verticals. The company also noted steady progress in its In Vitro Diagnostics business segment.
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.